Search results

  • Full text

  • Document type

    • Publication year

  • Organisation

Results: 32
Number of items: 32
  • Open Access
    Palomares Cabeza, V., Kummer, L. Y. L., Wieske, L., Hagen, R. R., Duurland, M., Konijn, V. A. L., van Dam, K. P. J., Stalman, E. W., van de Sandt, C. E., Boekel, L., Verstegen, N. J. M., Steenhuis, M., Rispens, T., Tas, S. W., Wolbink, G., Killestein, J., Kuijpers, T. W., van Ham, S. M., Eftimov, F., ... Target-to-B! (T2B!) SARS-CoV-2 study group (2022). Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod. Neurology® Neuroimmunology & Neuroinflammation, 9(4), Article e1178. https://doi.org/10.1212/NXI.0000000000001178
  • Open Access
    Jeucken, K. C. M. (2022). TNF receptor superfamily signaling in lymphoid organ development and endothelial cell responses. [Thesis, fully internal, Universiteit van Amsterdam].
  • Open Access
    Kaaij, M. H. (2022). Connecting inflammation, blood vessels and bone in spondyloarthritis. [Thesis, fully internal, Universiteit van Amsterdam].
  • Open Access
    Verstegen, N. J. M., Hagen, R. R., van den Dijssel, J., Kuijper, L. H., Kreher, C., Ashhurst, T., Kummer, L. Y. L., Steenhuis, M., Duurland, M., de Jongh, R., de Jong, N., van der Schoot, C. E., Bos, A. V., Mul, E., Kedzierska, K., van Dam, K. P. J., Stalman, E. W., Boekel, L., Wolbink, G., ... T2B! immunity against SARS-CoV-2 study group (2022). Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273. eLife, 11, Article e77969. https://doi.org/10.7554/eLife.77969
  • Open Access
    van Kempen, Z. L. E., Wieske, L., Stalman, E. W., Kummer, L. Y. L., van Dam, P. J., Volkers, A. G., Boekel, L., Toorop, A. A., Strijbis, E. M. M., Tas, S. W., Wolbink, G. J., Löwenberg, M., van Sandt, C., ten Brinke, A., Verstegen, N. J. M., Steenhuis, M., Kuijpers, T. W., van Ham, S. M., Rispens, T., ... T2B! immunity against SARS-CoV-2 study group (2022). Longitudinal humoral response after SARS-CoV-2 vaccination in ocrelizumab treated MS patients: To wait and repopulate? Multiple sclerosis and related disorders, 57, Article 103416. https://doi.org/10.1016/j.msard.2021.103416
  • Boekel, L., Steenhuis, M., Hooijberg, F., Besten, Y. R., van Kempen, Z. L. E., Kummer, L. Y., van Dam, K. P. J., Stalman, E. W., Vogelzang, E. H., Cristianawati, O., Keijzer, S., Vidarsson, G., Voskuyl, A. E., Wieske, L., Eftimov, F., van Vollenhoven, R., Kuijpers, T. W., van Ham, S. M., Tas, S. W., ... Wolbink, G. (2021). Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies. The Lancet. Rheumatology, 3(11), e778-e788. https://doi.org/10.1016/S2665-9913(21)00222-8
  • Boekel, L., Hooijberg, F., van Kempen, Z. L. E., Vogelzang, E. H., Tas, S. W., Killestein, J., Nurmohamed, M. T., Boers, M., Kuijpers, T. W., van Ham, S. M., Eftimov, F., Wieske, L., Rispens, T., & Wolbink, G. J. (2021). Perspective of patients with autoimmune diseases on COVID-19 vaccination. The Lancet. Rheumatology, 3(4), e241-e243. https://doi.org/10.1016/S2665-9913(21)00037-0
  • Open Access
    Maracle, C. X. (2018). NF-κB signaling in endothelial cells: Identification of NIK as a therapeutic target. [Thesis, fully internal, Universiteit van Amsterdam].
  • Open Access
    Maijer, K. I. (2017). Rheumatoid arthritis: From the at risk phases all the way up to the development of the disease. [Thesis, fully internal, Universiteit van Amsterdam].
  • Open Access
    Noort, A. R. (2015). Non-canonical NF-κB signaling in rheumatoid arthritis and beyond. [Thesis, fully internal, Universiteit van Amsterdam].
Page 3 of 4